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Analysis of themolecularmechanisms underlying somatic cell reprogramming into iPSCs is hampered by low
efficiency of conversion and resulting cellular heterogeneity. In this issue of Cell Stem Cell, Zunder et al.
(2015) utilize mass cytometry to perform high-throughput, single-cell analyses and provide a detailed molec-
ular roadmap of the reprogramming process.The reprogramming of somatic cells into
induced pluripotent stem cells (iPSCs)
provides opportunities to carefully study
mechanisms underlying flexibility and
reversibility of cell fate determination
(Sa´nchez Alvarado and Yamanaka,
2014). However, the low efficiency of con-
version and high heterogeneity within the
induced cell population raises significant
challenges for performing such analyses.
The characteristics of the small percent-
age of successfully reprogrammed cells
during their transition to pluripotency are
largely concealed by their incompletely
converted counterparts when popula-
tions are analyzed as a whole. Therefore,
a technique that can both examine the
expression of many genes at single-cell
resolution and analyze a large number
of single cells cost-effectively is highly
desired.
In this issue of Cell Stem Cell, Zunder
et al. applied single-cell mass cytometry
to trace the reprogramming process in
great detail (Zunder et al., 2015). This
technique is a variation of traditional
fluorescent flow cytometry; instead of
measuring fluorescence, specific anti-
bodies are conjugated to rare metal iso-
topes that are then detected via atomic
mass spectrometry (Bandura et al.,
2009). As single-cell mass cytometry min-
imizes interference due to spectral over-
lap, this technique allows simultaneous
detection of over 40 different parameters
in individual cells, compared with < 12 pa-
rameters in traditional fluorescent flow
cytometry. The authors further developed
computational tools for visualization of
these data in two dimensional space to
map the progression of single cells along
the reprogramming process. To further
capitalize on the high-throughput advan-tages of the mass cytometry approach,
the authors also utilized an elegant
mass-tag cellular barcoding strategy that
allows dozens of different samples to
be pooled together, processed, and
analyzed in a single tube. This minimizes
potential bias arising from variations in
handling different batches of samples
(Bodenmiller et al., 2012). Thus, this tech-
nique allows both high-throughput and
high-content analysis of the reprogram-
ming process at the single-cell level.
Zunder et al. (2015) examined sixteen
time points during somatic cell reprog-
ramming in three different inducible sys-
tems, including one primary mouse
embryonic fibroblast (MEF) and two sec-
ondary MEF reprogramming systems, to
obtain a continual and detailed molecular
roadmap of the reprogramming process
at single-cell resolution. Despite the dif-
ferences in stoichiometric expression of
reprogramming factors in these three sys-
tems, visualization of the datasets from
these approaches revealed striking com-
monalities, suggesting that there is a
general molecular route that cells follow
during the reprogramming process from
MEFs to iPSCs. A prominent Oct4high
Klf4high subpopulation was found at an
early time point of the process. Although
Oct4 and Klf4 have well-documented
roles during the early stages of reprog-
ramming (Radzisheuskaya and Silva,
2014; Li et al., 2010), the clear visualiza-
tion of this cell population early in the
continual roadmap highlights the impor-
tance of these factors in the initial stages
of iPSC generation. The authors also
confirmed previous findings that the
mesenchymal-epithelial transition (MET)
is a critical step during reprogramming
of mesenchymal cells, including MEFs,Cell Stem Cellinto iPSCs (Li et al., 2010). Their results
further suggest that incompletely reprog-
rammed cells are trapped between
the Oct4highKlf4high state and the comple-
tion of MET, and this partial reprogram-
ming state was characterized by a tran-
sient surface marker CD73highCD104high
CD54low pattern.
Later reprogramming stages were
shown to involve activation of endoge-
nous Nanog expression, followed by a
bifurcation into bona fide iPSCs or an
alternate endpoint population. The cells
in this abundant, alternative final cell pop-
ulation expressed lower levels of pluripo-
tency genes, including Oct4, Sox2, and
Nanog, and appeared to acquire a mes-
enendoderm-like state with elevated
expression of Lin28 and PDGFR-a.
Further investigations are required to fully
characterize this alternate final state to
understand the inefficiency of iPSC gen-
eration. The authors then assessed how
cell signaling states may affect cell paths
along this bifurcation. Since single-cell
mass cytometry is based on antibody
recognition, it is able to detect posttrans-
lational modifications for analysis of
cellular signaling pathways. The authors
measured ten signaling-associated pro-
tein modifications and identified a burst
of phospho-S6 during the later stages of
reprogramming of primary MEFs, indi-
cating activation of the PI3K/mTOR
pathway. Further drug inhibition experi-
ments demonstrated that the PI3K/
mTOR pathway was indeed functionally
essential for reprogramming of primary
MEFs into iPSCs.
This work demonstrates the power of
the mass cytometry technique for molec-
ular dissection of a cell fate determination
process, providing temporal snapshots at16, March 5, 2015 ª2015 Elsevier Inc. 215








Reconstructing cell lineage and gene
regulation network at single-cell resolution
Figure 1. Reconstructing the Steps of Cellular State Changes by High-Throughput, Single-
Cell Multiomics Analyses
Changes in cell state can be visualized in three stages: (I) the initial starting population; (II) transitioning,
intermediate cells; and (III) the final cell population. Ideally, progression through these stages can be
analyzed by putative high-throughput single-cell multiple omics technologies. In each individual cell,
the genome, epigenome, transcriptome, proteome, and metabolome are simultaneously analyzed, and
the intrinsic connections among these datasets are determined.When a sufficiently large number of single
cells at dense enough time points are analyzed, a continual and detailed cell-lineage map of the process
can be accurately reconstructed, and the gene regulation network within each individual cell will be
revealed.
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Previewssingle-cell resolution. In the future, it
should be especially useful for analysis
of small molecule-based reprogramming
methods and cellular transdifferentiation,
in which truly reprogrammed cells are
rare (Xu et al., 2015). A minor concern
for single-cell mass cytometry analysis is
how to distinguish technical noise from
biological variations of gene expression
among individual cells. One potential
solution is to measure a target protein in
the same single cell twice using two anti-
bodies tagged by different isotopes, and
thus the technical noise or measurement
uncertainties can be accurately deter-
mined for each target protein in each indi-
vidual cell.
Recent developments in single-cell
RNA-seq technology have increased
throughput to hundreds or even thou-216 Cell Stem Cell 16, March 5, 2015 ª2015sands of single cells, while at the same
time exponentially decreasing costs (Sha-
piro et al., 2013). Although single-cell
RNA-seq technology is still limited in
terms of throughput compared to mass
cytometry, its great advantage is that it
measures RNA expression at whole tran-
scriptome scale instead of a small subset
of selected genes. In the future, it may be
possible to combine these two comple-
mentary approaches for studying a dy-
namic and heterogeneous biological
process. For instance, single-cell RNA-
seq technology could be applied to
analyze a relatively small number of single
cells sorted from subpopulations of inter-
est by FACS to screen for candidate
markers or master genes. Then, a large
number of cells could be sampled and
intensively analyzed at serial time pointsElsevier Inc.by single-cell mass cytometry, using anti-
bodies targeting the identified candidates
to obtain a high-resolution roadmap. One
concern of such single-cell omics ana-
lyses is that they do not provide continual
cell lineage tracing, as live-cell imaging
does (Hoppe et al., 2014). However,
similar information can be obtained by
analyzing large numbers of cells at
frequent time points, as shown here by
Zunder et al. (2015). Furthermore, by
combining these single-cell approaches
with targeted gene editing of candidate
genes and mathematical modeling, inter-
rogation and reconstruction of the gene
regulation networks controlling cell-state
transitions can be accomplished.
Looking forward, the ideal tools for sin-
gle-cell analysis would provide both high-
throughput and high-content analysis,
simultaneously delivering information on
multiple aspects of cell state, including
the genome, epigenome, transcriptome,
proteome, and metabolome, within the
same individual cell (Figure 1) (Wen and
Tang, 2014). Such a technology will
make single cells an ideal test tube for
analyzing the gene networks that regulate
stem cell biology, greatly accelerating
progress in the stem cell field.
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